These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 20017729)

  • 1. Cannabinoid-opioid interactions in drug discrimination and self-administration: effect of maternal, postnatal, adolescent and adult exposure to the drugs.
    Spano MS; Fadda P; Fratta W; Fattore L
    Curr Drug Targets; 2010 Apr; 11(4):450-61. PubMed ID: 20017729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabinoids, opioids and MDMA: neuropsychological interactions related to addiction.
    Robledo P
    Curr Drug Targets; 2010 Apr; 11(4):429-39. PubMed ID: 20017726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional interactions between endogenous cannabinoid and opioid systems: focus on alcohol, genetics and drug-addicted behaviors.
    López-Moreno JA; López-Jiménez A; Gorriti MA; de Fonseca FR
    Curr Drug Targets; 2010 Apr; 11(4):406-28. PubMed ID: 20196742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous cannabinoid and opioid systems and their role in nicotine addiction.
    Maldonado R; Berrendero F
    Curr Drug Targets; 2010 Apr; 11(4):440-9. PubMed ID: 20017727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neurobiology of cannabinoid dependence: sex differences and potential interactions between cannabinoid and opioid systems.
    Ambrosio E; Martín S; García-Lecumberri C; Crespo JA
    Life Sci; 1999; 65(6-7):687-94. PubMed ID: 10462069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoid addiction: behavioral models and neural correlates.
    Maldonado R; Rodríguez de Fonseca F
    J Neurosci; 2002 May; 22(9):3326-31. PubMed ID: 11978807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular mechanisms underlying the interaction between cannabinoid and opioid system.
    Parolaro D; Rubino T; Viganò D; Massi P; Guidali C; Realini N
    Curr Drug Targets; 2010 Apr; 11(4):393-405. PubMed ID: 20017730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic changes of the endogenous cannabinoid and opioid mesocorticolimbic systems during adolescence: THC effects.
    Ellgren M; Artmann A; Tkalych O; Gupta A; Hansen HS; Hansen SH; Devi LA; Hurd YL
    Eur Neuropsychopharmacol; 2008 Nov; 18(11):826-34. PubMed ID: 18674887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabinoids and reward: interactions with the opioid system.
    Fattore L; Cossu G; Spano MS; Deiana S; Fadda P; Scherma M; Fratta W
    Crit Rev Neurobiol; 2004; 16(1-2):147-58. PubMed ID: 15581410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoids: reward, dependence, and underlying neurochemical mechanisms--a review of recent preclinical data.
    Tanda G; Goldberg SR
    Psychopharmacology (Berl); 2003 Sep; 169(2):115-34. PubMed ID: 12827346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of cannabinoid receptor in the brain as it relates to drug reward.
    Yamamoto T; Takada K
    Jpn J Pharmacol; 2000 Nov; 84(3):229-36. PubMed ID: 11138722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal exposure to delta9-tetrahydrocannabinol facilitates morphine self-administration behavior and changes regional binding to central mu opioid receptors in adult offspring female rats.
    Vela G; Martín S; García-Gil L; Crespo JA; Ruiz-Gayo M; Fernández-Ruiz JJ; García-Lecumberri C; Pélaprat D; Fuentes JA; Ramos JA; Ambrosio E
    Brain Res; 1998 Oct; 807(1-2):101-9. PubMed ID: 9757010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical Studies of Cannabinoid Reward, Treatments for Cannabis Use Disorder, and Addiction-Related Effects of Cannabinoid Exposure.
    Panlilio LV; Justinova Z
    Neuropsychopharmacology; 2018 Jan; 43(1):116-141. PubMed ID: 28845848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocannabinoid system and opioid addiction: behavioural aspects.
    Fattore L; Deiana S; Spano SM; Cossu G; Fadda P; Scherma M; Fratta W
    Pharmacol Biochem Behav; 2005 Jun; 81(2):343-59. PubMed ID: 15935459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The opioid systems--panacea and nemesis.
    Terenius L; Johansson B
    Biochem Biophys Res Commun; 2010 May; 396(1):140-2. PubMed ID: 20494127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compartment-specific localization of cannabinoid 1 (CB1) and mu-opioid receptors in rat nucleus accumbens.
    Pickel VM; Chan J; Kash TL; Rodríguez JJ; MacKie K
    Neuroscience; 2004; 127(1):101-12. PubMed ID: 15219673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of addiction risk potential associated with adolescent opioid use.
    Windisch KA; Kreek MJ
    Pharmacol Biochem Behav; 2020 Nov; 198():173022. PubMed ID: 32871141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects on development.
    Ramos JA; Gómez M; de Miguel R
    Handb Exp Pharmacol; 2005; (168):643-56. PubMed ID: 16596791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between cannabinoid receptor agonists and mu opioid receptor agonists in rhesus monkeys discriminating fentanyl.
    Maguire DR; France CP
    Eur J Pharmacol; 2016 Aug; 784():199-206. PubMed ID: 27184925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex-dependent effects of periadolescent exposure to the cannabinoid agonist CP-55,940 on morphine self-administration behaviour and the endogenous opioid system.
    Biscaia M; Fernández B; Higuera-Matas A; Miguéns M; Viveros MP; García-Lecumberri C; Ambrosio E
    Neuropharmacology; 2008 Apr; 54(5):863-73. PubMed ID: 18329053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.